Emerging drugs for complicated skin and skin-structure infections

Author： Mendoza Natalia   Tyring Stephen K  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.3, 2010-09, pp. : 509-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ceftaroline for complicated skin and skin-structure infections

By Nannini Esteban C   Stryjewski Martin E   Corey G Ralph  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1197-1206

Informa Healthcare

Access to resources Recommend Favorite

Daptomycin creates a niche in skin and skin-structure infections

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections

By Itani Kamal M.F.  

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 421-430

Adis International

Access to resources Recommend Favorite

Moxifloxacin: In Uncomplicated Skin and Skin Structure Infections

By Muijsers R.B.R.   Jarvis B.  

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 967-973

Adis International

Access to resources Recommend Favorite

Treatment of bacterial skin and skin structure infections

By Guay David RP  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1259-1275

Informa Healthcare

Access to resources Recommend Favorite